Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Serine Protease Inhibitor Kazal Type 1 (SPINK1) c.194+2T > C Mutation May Predict Long-term Outcome of Endoscopic Treatments in Idiopathic Chronic Pancreatitis.

Medicine - 1 Nov 2015

Sun Chang, Liu Mu-Yun, Liu Xiao-Gang, Hu Liang-Hao, Xia Tian, Liao Zhuan, Li Zhao-Shen

Abstract excerpt

Endoscopic interventional is a commonly used treatment method for idiopathic chronic pancreatitis. Serine protease inhibitor Kazal type 1 (SPINK1) 194+2T>C mutation is most frequently observed in Chinese pancreatitis patients and influences the clinical course of idiopathic chronic pancreatitis patients. We conducted this study to determine the impacts of this mutation on the outcome of endoscopic treatments.In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carrier Proteins
Share to Diabetes Mellitus

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Exocrine Pancreatic Insufficiency

Share to Genetic Testing

Share to Pancreatitis, Chronic

Share to Postoperative Complications

Share to Predictive Value of Tests

Share to Trypsin Inhibitor, Kazal Pancreatic

Source

Open in PubMed Open full text

Identifiers

PMID: 26632706
DOI: 10.1097/MD.0000000000002046
PMCID: PMC5058975

Genes

SPINK1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Serine Protease Inhibitor Kazal Type 1 (SPINK1) c.194+2T > C Mutation May Predict Long-term Outcome of Endoscopic Treatments in Idiopathic Chronic Pancreatitis.PMID 26632706Read ↗

The contribution of the SPINK1 c.194+2T>C mutation to the clinical course of idiopathic chronic pancreatitis in Chinese patients.Semantic proximity Read ↗

Serine Protease Inhibitor Kazal Type I (SPINK1) Mutation: A Risk Factor for Early-onset Chronic Pancreatitis?Semantic proximity Read ↗

SPINK1, ADH2, and ALDH2 gene variants and alcoholic chronic pancreatitis in Japan.Semantic proximity Read ↗

Genetic Abnormalities in Pancreatitis: An Update on Diagnosis, Clinical Features, and TreatmentSemantic proximity Read ↗

Clinical Features and Endoscopic Treatment of Chinese Patients With Hereditary Pancreatitis.Semantic proximity Read ↗

Heterozygous Spink1 c.194+2T>C mutation promotes chronic pancreatitis after acute attack in mice.Semantic proximity Read ↗

Mutations in the serine protease inhibitor Kazal Type 1 (SPINK1) gene in Japanese patients with pancreatitis.Semantic proximity Read ↗

Differential roles of the SPINK1 gene mutations in alcoholic and nonalcoholic chronic pancreatitis.Semantic proximity Read ↗

Genetics and clinical implications of SPINK1 in the pancreatitis continuum and pancreatic cancer.Semantic proximity Read ↗

Clinical interpretation of SPINK1 and CTRC variants in pancreatitis.Semantic proximity Read ↗

[SPINK1 N34S mutation as a possible cause of chronic pancreatitis in a patient with familial background].Semantic proximity Read ↗

Phenotypic variability of the homozygous IVS3+2T>C mutation in the serine protease inhibitor Kazal type 1 (SPINK1) gene in patients with chronic pancreatitis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.